Aflac Incorporated (NYSE:AFL) Shares Sold by Buffington Mohr McNeal

Buffington Mohr McNeal decreased its position in Aflac Incorporated (NYSE:AFL) by 18.6% in the 4th quarter, Holdings Channel reports. The fund owned 2,910 shares of the financial services provider’s stock after selling 666 shares during the period. Buffington Mohr McNeal’s holdings in Aflac were worth $240,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. BKM Wealth Management LLC acquired a new stake in shares of Aflac during the fourth quarter worth approximately $1,558,000. Nordea Investment Management AB grew its position in shares of Aflac by 25.9% during the fourth quarter. Nordea Investment Management AB now owns 1,693,249 shares of the financial services provider’s stock worth $139,676,000 after buying an additional 348,400 shares in the last quarter. G&S Capital LLC grew its position in shares of Aflac by 65.1% during the fourth quarter. G&S Capital LLC now owns 31,825 shares of the financial services provider’s stock worth $2,626,000 after buying an additional 12,551 shares in the last quarter. DekaBank Deutsche Girozentrale grew its position in shares of Aflac by 7.5% during the fourth quarter. DekaBank Deutsche Girozentrale now owns 376,087 shares of the financial services provider’s stock worth $30,786,000 after buying an additional 26,338 shares in the last quarter. Finally, Kestra Private Wealth Services LLC grew its position in shares of Aflac by 12.7% during the third quarter. Kestra Private Wealth Services LLC now owns 48,745 shares of the financial services provider’s stock worth $3,741,000 after buying an additional 5,477 shares in the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac Price Performance

Shares of NYSE AFL opened at $80.42 on Wednesday. Aflac Incorporated has a fifty-two week low of $64.10 and a fifty-two week high of $86.26. The firm’s 50-day simple moving average is $82.03 and its 200 day simple moving average is $81.47. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.33. The stock has a market cap of $46.27 billion, a P/E ratio of 10.38, a P/E/G ratio of 2.20 and a beta of 0.91.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). Aflac had a net margin of 24.92% and a return on equity of 17.59%. The company had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $4.44 billion. During the same quarter in the prior year, the firm earned $1.29 earnings per share. Equities analysts expect that Aflac Incorporated will post 6.41 EPS for the current year.

Insider Activity at Aflac

In other Aflac news, Director Arthur Reginald Collins sold 3,000 shares of the business’s stock in a transaction dated Thursday, February 22nd. The shares were sold at an average price of $79.73, for a total value of $239,190.00. Following the sale, the director now directly owns 5,592 shares in the company, valued at $445,850.16. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Aflac news, Director Arthur Reginald Collins sold 3,000 shares of the business’s stock in a transaction dated Thursday, February 22nd. The shares were sold at an average price of $79.73, for a total value of $239,190.00. Following the sale, the director now directly owns 5,592 shares in the company, valued at $445,850.16. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Masatoshi Koide sold 30,493 shares of the business’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $79.91, for a total transaction of $2,436,695.63. Following the completion of the sale, the director now owns 86,090 shares in the company, valued at $6,879,451.90. The disclosure for this sale can be found here. Insiders have sold a total of 46,493 shares of company stock worth $3,765,706 over the last ninety days. 0.80% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research firms have recently weighed in on AFL. Keefe, Bruyette & Woods raised their price target on shares of Aflac from $83.00 to $87.00 and gave the stock a “market perform” rating in a research report on Wednesday, April 10th. Wells Fargo & Company decreased their price objective on shares of Aflac from $83.00 to $81.00 and set an “equal weight” rating for the company in a report on Thursday, April 11th. UBS Group lifted their price objective on shares of Aflac from $80.00 to $84.00 and gave the stock a “neutral” rating in a report on Wednesday, January 10th. The Goldman Sachs Group lifted their price objective on shares of Aflac from $61.00 to $75.00 and gave the stock a “sell” rating in a report on Tuesday, January 9th. Finally, StockNews.com downgraded shares of Aflac from a “hold” rating to a “sell” rating in a report on Wednesday, April 10th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $82.15.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.